Expression of cathepsin-D, CA125 and epidermal growth factor receptor in imprint smears of ovarian carcinoma

被引:2
作者
Athanassiadou, P
Sakellariou, V
Michalas, S
Petrakakou, E
Zerva, C
Athanassiades, P
Aravantinos, D
机构
[1] UNIV ATHENS,SCH MED,ALEXANDRA HOSP,PATHOL DEPT,CYTOL LAB,GR-11527 ATHENS,GREECE
[2] UNIV ATHENS,SCH MED,ALEXANDRA HOSP,DEPT OBSTET & GYNECOL 1,GR-11527 ATHENS,GREECE
关键词
immunocytochemistry; ovarian carcinoma; risk factors; cathepsin-D; CA125; epidermal growth factor receptor;
D O I
10.1159/000291837
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
One hundred primary ovarian cancers were studied for the expression of cathepsin-D, CA125 and epidermal growth factor receptor (EGF-R) by staining of imprint smears from freshly obtained surgical specimens. Estrogen and progesterone receptors of the primary tumor, lymph node invasion, menopausal status of the patients and primary tumor size were also noted. The polymorphism of the antigenic characteristics of ovarian carcinomas was noted and significant associations of EGF-R positivity and lymph node negativity, EGF-R positivity and serous carcinomas, EGF-R positivity and cathepsin-D positivity, cathepsin-D positivity and CA125 positivity, and CA125 positivity and serous carcinomas were observed. The high incidence of cathepsin-D positivity makes it a possible complementary method to CA125 for following up patients. It is suggested that complete antigenic profiles of individual tumors are more likely to provide accurate prognostic information in individual cases.
引用
收藏
页码:125 / 130
页数:6
相关论文
共 32 条
[1]   EPIDERMAL GROWTH-FACTOR RECEPTOR EXPRESSION IN GYNECOLOGICAL MALIGNANCIES [J].
BATTAGLIA, F ;
SCAMBIA, G ;
PANICI, PB ;
BAIOCCHI, G ;
PERRONE, L ;
IACOBELLI, S ;
MANCUSO, S .
GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 1989, 27 (01) :42-44
[2]   THE OCCURRENCE OF EPIDERMAL GROWTH-FACTOR RECEPTORS AND THE CHARACTERIZATION OF EGF-LIKE FACTORS IN HUMAN OVARIAN, ENDOMETRIAL, CERVICAL AND BREAST-CANCER - EGF RECEPTORS AND FACTORS IN GYNECOLOGICAL CARCINOMAS [J].
BAUKNECHT, T ;
KOHLER, M ;
JANZ, I ;
PFLEIDERER, A .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1989, 115 (02) :193-199
[3]  
BRAND E, 1993, OBSTET GYNECOL, V81, P29
[4]   MEDICAL PROGRESS - CANCER OF THE OVARY [J].
CANNISTRA, SA .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (21) :1550-1559
[5]  
DERDCHUCK A, 1990, OBSTET GYNECOL, V75, P255
[6]  
GALLION HH, 1993, CANCER RES, V53, P3839
[7]  
HARDING M, 1990, CANCER, V65, P486, DOI 10.1002/1097-0142(19900201)65:3<486::AID-CNCR2820650319>3.0.CO
[8]  
2-C
[9]   THE EPIDEMIOLOGY OF OVARIAN-CARCINOMA AND THE CURRENT STATUS OF TUMOR-MARKERS TO DETECT DISEASE [J].
HERBST, AL .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1994, 170 (04) :1099-1107
[10]   USE OF AVIDIN-BIOTIN-PEROXIDASE COMPLEX (ABC) IN IMMUNOPEROXIDASE TECHNIQUES - A COMPARISON BETWEEN ABC AND UNLABELED ANTIBODY (PAP) PROCEDURES [J].
HSU, SM ;
RAINE, L ;
FANGER, H .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1981, 29 (04) :577-580